Dermata Therapeutics, Inc. DRMA 深 沪
交易中 05-11 10:58:56 美东时间
1.2435
-0.016
-1.31%
华盛通- 最 高1.32
- 今 开1.26
- 成交量 1.01万股
- 最 低 1.2301
- 昨 收 1.26
- 总市值 1147.40万
- 52周最高 7.14
- 市盈率 静 --
- 换手率 0.11%
- 52周最低 0.5739
- 委 比 60.00%
- 总股本 922.72万
- 历史最高 7.14
- 量 比 1.14
- 振 幅 7.13%
- 历史最低 0.14
- 每 手 1
- 风险率 1.79%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Dermata Shares Rise After USPTO Issues Patent Notice Of Allowance
Dermata Therapeutics shares are trading higher Friday after the USPTO issued a notice of allowance for a patent on skin condition treatment.
03-20 22:39
Why Fonar Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
Shares of Fonar Corp (NASDAQ:FONR) rose sharply in pre-market after the company...
2025-12-30 17:43
Reported Earlier, Dermata Therapeutics Raises $3.5M Through Private Placement, Offering 1.9M Shares And Warrants
The gross proceeds from the offering are expected to be approximately $3.5 million, prior to deducting placement agent's fees and other offering expenses payable by the Company. The Company intends to use
2024-09-17 15:07
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
Shares of Exicure, Inc. (NASDAQ:XCUR) rose sharply in today's pre-market tradin...
2024-09-16 18:07
Texas Instruments To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Jefferies raised the price target for BrightView Holdings, Inc. (NYSE:BV) from $13 to $17. Jefferies analyst S...
2024-08-21 20:58
Maxim Group Maintains Buy on Dermata Therapeutics, Lowers Price Target to $6
Maxim Group analyst Anthony Vendetti maintains Dermata Therapeutics (NASDAQ:DRMA) with a Buy and lowers the price target from $10 to $6.
2024-08-21 20:21
